Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-02-02-2011
Volume35
Issue 2

Pharmaceutical Technology, February 2011 Issue (PDF)

Real Time Release Testing

External Link - article-818923.pdf

Articles in this issue
Pharmaceutical Technology, February 2011 Issue (PDF)
i1-707059-1417779456482.jpg
FDA Perspectives: Common Deficiencies in Abbreviated New Drug Applications: Part 3 - Control of the Drug Product and Stability
SMART Bioprocess Design
i1-707045-1408628396910.jpg
Follow-Ons: The New Black?
Real Time Release Testing
Real Time Release Testing
i1-707048-1408628390442.jpg
Rogue Pharmacies

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
PharmTech Weekly News Roundup
Related Content
Famous Radcliffe Camera in the Oxford University - aerial view | Image Credit: © 4kclips - stock.adobe.com
September 4th 2025

Oxford, EIT Address Urgent Problem with AI Vaccine Research

Patrick Lavery
Drug Solutions Podcast: Sustainable Solutions for Biopharma
September 4th 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
Blockchain for transparent supply chain tracking | Image Credit: ©Andrey -stock.adobe.com
September 4th 2025

Keys to Navigating the Complex Drug Supply Chain

Susan Haigney
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
September 4th 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com
September 4th 2025

Effectively Using Contamination Control Strategies

Michelle Heiter Susan J. Schniepp
David Cali is senior director of Security & DEA Compliance at Reworld.
September 4th 2025

Manufacturer Guidelines for the Secure Destruction of Controlled Substance Pharmaceuticals

David Cali
© 2025 MJH Life Sciences

All rights reserved.